From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity

References

• Lao TT. Immune persistence after hepatitis B vaccination in infancy – fact or fancy? Hum Vaccin Immunother. 2016;12:1172–6. doi:10.1080/21645515.2015.1130195.
   PubMed Web of Science ®Google Scholar
• Trevisan A. Long-term persistence of immunity after hepatitis B vaccination: A fact, not a fancy. Hum Vaccin Immunother. 2017;13:916–7. doi:10.1080/21645515.2016.1257451.
   PubMed Web of Science ®Google Scholar
• Lao TT. Long-term persistence of immunity after hepatitis B vaccination: Is this substantiated by the literature? Hum Vaccin Immunother. 2017;13:918–20. doi:10.1080/21645515.2016.1267084.
   PubMed Web of Science ®Google Scholar
• Carmody E. Time to re-evaluate the effect of the adolescent booster of hepatitis B vaccine. Int J Infect Dis. 2017;60:88–90. doi:10.1016/j.ijid.2017.04.019.
   PubMed Web of Science ®Google Scholar
• Zhou Y. Be cautious for exceptional results in evaluating the effect of adolescent booster of hepatitis B vaccine. Int J Infect Dis. 2018;66:150–2. doi:10.1016/j.ijid.2017.11.008.
   PubMed Web of Science ®Google Scholar
• Schönberger K, Riedel C, Rückinger S, Mansmann U, Jilg W, Kries R. Determinants of long-term protection after hepatitis B vaccination in infancy: A meta-analysis. Pediatr Infect Dis J. 2013;32:307–13. doi:10.1097/INF.0b013e31827bd1b0.
   PubMed Web of Science ®Google Scholar
• FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B vaccination: A completed schedule enough to control HBV lifelong? Milan, Italy, 17–18 November 2011. Vaccine. 2013;31(4):584–90. doi:10.1016/j.vaccine.2012.10.101.
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev. 2016;(6):CD008256. doi:10.1002/14651858.CD008256.pub3.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Global health sector strategy on viral hepatitis 2016–2021; towards ending viral hepatitis. June, 2016. http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed August, 2016.
   Google Scholar
• World Health Organization (WHO). Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations. Vaccine. 2017; S0264-410X(17)30954-4. doi:10.1016/j.vaccine.2017.07.046. [Epub ahead of print]
   Google Scholar
• Hong M, Bertoletti A. Tolerance and immunity to pathogens in early life: Insights from HBV infection. Semin Immunopathol. 2017;39(6):643–52. doi:10.1007/s00281-017-0641-1.
   PubMed Web of Science ®Google Scholar
• Siegrist C, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9(3):185–94. doi:10.1038/nri2508.
   PubMed Web of Science ®Google Scholar
• Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review. Vaccine. 2013;31:2506–16. doi:10.1016/j.vaccine.2012.12.012.
   PubMed Web of Science ®Google Scholar
• Mohr E, Siegrist C. Vaccination in early life: Standing up to the challenges. Curr Opin Immunol. 2016;41:1–8. doi:10.1016/j.coi.2016.04.004.
   PubMed Web of Science ®Google Scholar
• Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Whittle H, Lambert PH, McAdam KP, Siegrist CA, Marchant A. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine. 2004;22(3-4):511–9.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang S, Luo C, Wu Q, Liu Q, Zhou YH, Hu Y. Transplacentally acquired maternal antibody against hepatitis B surface antigen in infants and its influence on the response to hepatitis B vaccine. PLoS ONE. 2011;6(9):e25130. doi:10.1371/journal.pone.0025130.
   PubMed Web of Science ®Google Scholar
• Edwards KM. Maternal antibodies and infant immune responses to vaccines. Vaccine. 2015;33(47):6469–72. doi:10.1016/j.vaccine.2015.07.085.
   PubMed Web of Science ®Google Scholar
• Greenberg DP. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J. 1993;12(5):438–45.
   PubMed Web of Science ®Google Scholar
• Da Villa G, Pelliccia MG, Peluso F, Ricciardi E, Sepe A. Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine. Res Virol. 1997;148(2):109–14.
   PubMedGoogle Scholar
• Venters C, Graham W, Cassidy W. Recombivax-HB: Perspectives past, present and future. Expert Rev Vaccines. 2004;3(2):119–29.
   PubMedGoogle Scholar
• Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR. Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014;133(6):e1500–1507. doi:10.1542/peds.2013-2940.
   PubMed Web of Science ®Google Scholar
• Gagneur A, Pinquier D, Quach C. Immunization of preterm infants. Hum Vaccin Immunother. 2015;11(11):2556–63. doi:10.1080/21645515.2015.
   PubMed Web of Science ®Google Scholar
• Saso A, Kampmann B. Vaccine responses in newborns. Semin Immunopathol. 2017;39(6):627–42. doi:10.1007/s00281-017-0654-9.
   PubMed Web of Science ®Google Scholar
• Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, Levy O. Protecting the newborn and young infant from infectious diseases: Lessons from immune ontogeny. Immunity. 2017;46(3):350–63. doi:10.1016/j.immuni.2017.03.009.
   PubMed Web of Science ®Google Scholar
• Philbin VJ, Levy O. Developmental biology of the innate immune response: Implications for neonatal and infant vaccine development. Pediatr Res. 2009;65(5 Pt 2):98R–105R. doi:10.1203/PDR.0b013e31819f195d.
   PubMed Web of Science ®Google Scholar
• Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J. 2008 Oct;27(10):881–5. doi:10.1097/INF.0b013e31817702ba.
   PubMed Web of Science ®Google Scholar
• Roznovsky L, Orsagova I, Kloudova A, Tvrdik J, Kabieszova L, Lochman I, Mrazek J, Hozakova L, Zjevikova A, Pliskova L. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection. 2010;38(5):395–400. doi:10.1007/s15010-010-0039-7.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68–75. doi:10.1093/cid/cir270.
   PubMed Web of Science ®Google Scholar
• Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics. 2007;120(2):e373–381.
   PubMed Web of Science ®Google Scholar
• Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine. 2012;30:1644–9. doi:10.1016/j.vaccine.2011.12.106.
   PubMed Web of Science ®Google Scholar
• Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis. 2001;184(7):905–8.
   PubMed Web of Science ®Google Scholar
• Coppola N, Corvino A, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, Sagnelli E, Lamberti M. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy. BMC Infect Dis. 2015;15:149. doi:10.1186/s12879-015-0874-3.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, et al. Antibody levels and protection after hepatitis B vaccine: Results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16–22. doi:10.1093/infdis/jiv748.
   PubMed Web of Science ®Google Scholar
• Pinto M, Dawar M, Krajden M, Naus M, Scheifele DW. Will infant hepatitis B vaccination protect into adulthood? Extended Canadian experience after a 2-, 4- and 6-month immunization schedule. Pediatr Infect Dis J. 2017;36(6):609–15. doi:10.1097/INF.0000000000001543.
   PubMed Web of Science ®Google Scholar
• Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20(4):607–28. doi:10.1016/j.cld.2016.06.006.
   PubMed Web of Science ®Google Scholar
• Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades – A global analysis. J Hepatol. 2017;66(1):48–54. doi:10.1016/j.jhep.2016.08.013.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhou Y. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother. 2018;14:456–63. doi:10.1080/21645515.2017.1397243.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, (CDC). Recommended childhood immunization schedule – United States, 1999. MMWR. 1999;48(1):12–16.
   PubMedGoogle Scholar
• Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, et al. Persistence of antibody to hepatitis B and protections from disease among Alaska Natives immunized at birth. Pediatr Infect Dis J. 2005;24:786–92.
   PubMed Web of Science ®Google Scholar
• Stevens CE, Toy P, Kamili S, Taylor PE, Tong MJ, Xia GL, Vyas GN. Eradicating hepatitis B virus: The critical role of preventing perinatal transmission. Biologicals. 2017;50:3–19. doi:10.1016/j.biologicals.2017.08.008.
   PubMed Web of Science ®Google Scholar
• Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, Parkinson AJ. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004;23(7):650–5.
   PubMed Web of Science ®Google Scholar
• Hammitt L, Hennessy T, Fiore A, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years. Vaccine. 2007;25(39-40):6958–64.
   PubMed Web of Science ®Google Scholar
• Kang G, Chen H, Ma F, Yang Y, Wang Z, Guo S, Song J. Comparison of the effect of increased hepatitis B vaccine dosage on immunogenicity in healthy children and adults. Hum Vaccin Immunother. 2016;12(9):2312–6. doi:10.1080/21645515.2016.1172757.
   PubMed Web of Science ®Google Scholar
• Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72. doi:10.3201/eid2305.161477.
   PubMed Web of Science ®Google Scholar
• Baclic O, Choudhri Y, Henry B, Ismail S, Morton V. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). Update on the recommended use of hepatitis B vaccine. 2017. Public Health Agency of Canada. Available at https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci.html. Accessed October 2017.
   Google Scholar
• Gilca V, De Serres G, Boulianne N, Murphy D, Ouakki M, De Wals P, Trudeau G, Massé R, Dionne M. Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine. Hum Vaccin Immunother. 2013;9(8):1685–90. doi:10.4161/hv.25015.
   PubMed Web of Science ®Google Scholar
• Pinto M, Scheifele D. Discussing the need for an adolescent hepatitis B vaccine booster in infant vaccinees. Paediatr Child Health. 2014;19(8):404.
   PubMed Web of Science ®Google Scholar
• Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Vaccine. 2017;35(35 Pt B):4515–22. doi:10.1016/j.vaccine.2017.07.040.
   PubMed Web of Science ®Google Scholar
• Simons BC, Spradling PR, Bruden D, Zanis C, Case S, Choromanski TL, Apodaca M, Brogdon HD, Dwyer G, Snowball M, et al. A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen. J Infect Dis. 2016;214(2):273–80. doi:10.1093/infdis/jiw142.
   PubMed Web of Science ®Google Scholar
• Werner JM, Abdalla A, Gara N, Ghany MG, Rehermann B. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity. Gastroenterology. 2013;145(5):1026–34. doi:10.1053/j.gastro.2013.07.044.
   PubMed Web of Science ®Google Scholar